The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1355
January 10, 2011
View Complete Issue         Table of Contents 2019 
Ella: A New Emergency Contraceptive
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Ella: A New Emergency Contraceptive
January 10, 2011 (Issue: 1355)
The FDA has approved the use of ulipristal acetate (ella – Watson) as an emergency contraceptive that can be taken up to 5 days after unprotected intercourse. It is available only by prescription.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Ella: A New Emergency Contraceptive
Article code: 1355c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.